Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine + Chinese Traditional Medicine Maintenance in mCRC
NCT02575378Phase 4Unknown
- Sponsor
- Ruijin Hospital
- Start
- Sep 2015
- Primary completion
- Jun 2018
- Modality
- HMF (Herbal Medicine Formulation)
01
Overview
A Phase 4 trial of bazhengsan in metastatic colorectal cancer (mCRC), sponsored by Ruijin Hospital. Status: unknown.
02
Drugs
bazhengsan
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT02575378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02575378.